Europe Muscle Relaxant Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Route of Administration (Oral and Injectable), By Distribution Channel, By Country and Growth Forecast, 2023

List of Tables

The Europe Muscle Relaxant Drugs Market would witness market growth of 4.1% CAGR during the forecast period (2023-2029).

Direct-acting muscle relaxants are employed as anesthetics during surgery and on a long-term basis to permit controlled mechanical ventilation in intensive care unit patients. Relaxants with a central mechanism of action are additionally referred to as spasmolytic agents. These work by blocking neuronal pathways in the brain and spinal cord that are overly stimulated. Agents with spasmolytic properties are beneficial for managing musculoskeletal pain and spasm.

The primary trend that is expected to gain traction in the market is product innovation. To maintain their position in the market, major players are creating novel pharmaceuticals for certain medical uses, such as generic muscle relaxants, muscle relaxants for animals, drugs that allow for flexible, individualized dosing, and others. For instance, there are now drugs available to treat the spasticity brought on by multiple sclerosis and other spinal cord illnesses. These drugs provide flexible, individualized dose packets of granules intended to treat multiple sclerosis-related muscle stiffness, discomfort, and spasms.

20% of individuals in the United Kingdom see a doctor annually for musculoskeletal (MSK) issues. Multiple risk factors can increase a person's susceptibility to MSK problems, including being overweight or obese, physical inactivity, consuming a diet deficient in vitamin D or calcium, smoking, advancing age, and genetic susceptibility to certain MSK conditions. Consequently, the high prevalence of musculoskeletal health will increase the demand for muscle relaxant drugs to treat musculoskeletal disorders, thereby boosting the market growth in the region.

The Germany market dominated the Europe Muscle Relaxant Drugs Market by Country in 2022 thereby, achieving a market value of $316.8 Million by 2029. The UK market is experiencing a CAGR of 3.2% during (2023 - 2029). Additionally, The France market would exhibit a CAGR of 4.9% during (2023 - 2029).

Based on Drug Type, the market is segmented into Skeletal, Neuromuscular Blocking Agents and Facial Muscle Relaxant Drugs. Based on Route of Administration, the market is segmented into Oral and Injectable. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy and Online Pharmacies. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Amneal Pharmaceuticals, Inc., Ipsen Pharma Biotech SAS, Merz Pharma GmbH & Co. KGaA, Mallinckrodt PLC, Teva Pharmaceuticals Industries Ltd., Eisai Co., Ltd., Endo International PLC, Vertical Pharmaceuticals, LLC, SteriMax Inc., and Metacel Pharmaceuticals, LLC.

Scope of the Study

Market Segments covered in the Report:

By Drug Type

Skeletal
Neuromuscular Blocking Agents
Facial Muscle Relaxant Drugs

By Route of Administration

Oral
Injectable

By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacies

By Country

Germany
UK
France
Russia
Spain
Italy
Rest of Europe

Companies Profiled

Amneal Pharmaceuticals, Inc.
Ipsen Pharma Biotech SAS
Merz Pharma GmbH & Co. KGaA
Mallinckrodt PLC
Teva Pharmaceuticals Industries Ltd.
Eisai Co., Ltd.
Endo International PLC
Vertical Pharmaceuticals, LLC
SteriMax Inc.
Metacel Pharmaceuticals, LLC

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Europe Muscle Relaxant Drugs Market, by Drug Type
- 1.4.2 Europe Muscle Relaxant Drugs Market, by Route of Administration
- 1.4.3 Europe Muscle Relaxant Drugs Market, by Distribution Channel
- 1.4.4 Europe Muscle Relaxant Drugs Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview

2.1 Introduction
- 2.1.1 Overview
  - 2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints

Chapter 3. Europe Muscle Relaxant Drugs Market by Drug Type

3.1 Europe Skeletal Market by Country
3.2 Europe Neuromuscular Blocking Agents Market by Country
3.3 Europe Facial Muscle Relaxant Drugs Market by Country

Chapter 4. Europe Muscle Relaxant Drugs Market by Route of Administration

4.1 Europe Oral Market by Country
4.2 Europe Injectable Market by Country

Chapter 5. Europe Muscle Relaxant Drugs Market by Distribution Channel

5.1 Europe Hospital Pharmacy Market by Country
5.2 Europe Retail Pharmacy Market by Country
5.3 Europe Online Pharmacies Market by Country

Chapter 6. Europe Muscle Relaxant Drugs Market by Country

6.1 Germany Muscle Relaxant Drugs Market
- 6.1.1 Germany Muscle Relaxant Drugs Market by Drug Type
- 6.1.2 Germany Muscle Relaxant Drugs Market by Route of Administration
- 6.1.3 Germany Muscle Relaxant Drugs Market by Distribution Channel
6.2 UK Muscle Relaxant Drugs Market
- 6.2.1 UK Muscle Relaxant Drugs Market by Drug Type
- 6.2.2 UK Muscle Relaxant Drugs Market by Route of Administration
- 6.2.3 UK Muscle Relaxant Drugs Market by Distribution Channel
6.3 France Muscle Relaxant Drugs Market
- 6.3.1 France Muscle Relaxant Drugs Market by Drug Type
- 6.3.2 France Muscle Relaxant Drugs Market by Route of Administration
- 6.3.3 France Muscle Relaxant Drugs Market by Distribution Channel
6.4 Russia Muscle Relaxant Drugs Market
- 6.4.1 Russia Muscle Relaxant Drugs Market by Drug Type
- 6.4.2 Russia Muscle Relaxant Drugs Market by Route of Administration
- 6.4.3 Russia Muscle Relaxant Drugs Market by Distribution Channel
6.5 Spain Muscle Relaxant Drugs Market
- 6.5.1 Spain Muscle Relaxant Drugs Market by Drug Type
- 6.5.2 Spain Muscle Relaxant Drugs Market by Route of Administration
- 6.5.3 Spain Muscle Relaxant Drugs Market by Distribution Channel
6.6 Italy Muscle Relaxant Drugs Market
- 6.6.1 Italy Muscle Relaxant Drugs Market by Drug Type
- 6.6.2 Italy Muscle Relaxant Drugs Market by Route of Administration
- 6.6.3 Italy Muscle Relaxant Drugs Market by Distribution Channel
6.7 Rest of Europe Muscle Relaxant Drugs Market
- 6.7.1 Rest of Europe Muscle Relaxant Drugs Market by Drug Type
- 6.7.2 Rest of Europe Muscle Relaxant Drugs Market by Route of Administration
- 6.7.3 Rest of Europe Muscle Relaxant Drugs Market by Distribution Channel

Chapter 7. Company Profiles

7.1 Amneal Pharmaceuticals, Inc.
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Segmental Analysis
- 7.1.4 Research & Development Expenses
- 7.1.5 Recent strategies and developments:
  - 7.1.5.1 Acquisition and Mergers:
7.2 Ipsen Pharma Biotech SAS
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Regional Analysis
- 7.2.4 Research & Development Expense
- 7.2.5 Recent strategies and developments:
  - 7.2.5.1 Product Launches and Product Expansions:
7.3 Merz Pharma GmbH & Co. KGaA
- 7.3.1 Company Overview
7.4 Mallinckrodt PLC
- 7.4.1 Company Overview
- 7.4.2 Financial Analysis
- 7.4.3 Segmental and Regional Analysis
- 7.4.4 Research & Development Expense
7.5 Teva Pharmaceutical Industries Ltd.
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Regional Analysis
- 7.5.4 Research & Development Expenses
7.6 Eisai Co., Ltd.
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Segmental and Regional Analysis
- 7.6.4 Research & Development Expenses
7.7 Endo International PLC
- 7.7.1 Company Overview
- 7.7.2 Financial Analysis
- 7.7.3 Segmental Analysis
- 7.7.4 Research & Development Expense
7.8 Vertical Pharmaceuticals, LLC
- 7.8.1 Company Overview
7.9 SteriMax Inc.
- 7.9.1 Company Overview
7.10. Metacel Pharmaceuticals, LLC.
- 7.10.1 Company Overview

LIST OF TABLES

TABLE 1 Europe Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
TABLE 2 Europe Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
TABLE 3 Europe Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 4 Europe Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 5 Europe Skeletal Market by Country, 2019 - 2022, USD Million
TABLE 6 Europe Skeletal Market by Country, 2023 - 2029, USD Million
TABLE 7 Europe Neuromuscular Blocking Agents Market by Country, 2019 - 2022, USD Million
TABLE 8 Europe Neuromuscular Blocking Agents Market by Country, 2023 - 2029, USD Million
TABLE 9 Europe Facial Muscle Relaxant Drugs Market by Country, 2019 - 2022, USD Million
TABLE 10 Europe Facial Muscle Relaxant Drugs Market by Country, 2023 - 2029, USD Million
TABLE 11 Europe Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 12 Europe Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 13 Europe Oral Market by Country, 2019 - 2022, USD Million
TABLE 14 Europe Oral Market by Country, 2023 - 2029, USD Million
TABLE 15 Europe Injectable Market by Country, 2019 - 2022, USD Million
TABLE 16 Europe Injectable Market by Country, 2023 - 2029, USD Million
TABLE 17 Europe Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 18 Europe Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 19 Europe Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 20 Europe Hospital Pharmacy Market by Country, 2023 - 2029, USD Million
TABLE 21 Europe Retail Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 22 Europe Retail Pharmacy Market by Country, 2023 - 2029, USD Million
TABLE 23 Europe Online Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 24 Europe Online Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 25 Europe Muscle Relaxant Drugs Market by Country, 2019 - 2022, USD Million
TABLE 26 Europe Muscle Relaxant Drugs Market by Country, 2023 - 2029, USD Million
TABLE 27 Germany Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
TABLE 28 Germany Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
TABLE 29 Germany Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 30 Germany Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 31 Germany Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 32 Germany Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 33 Germany Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 34 Germany Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 35 UK Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
TABLE 36 UK Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
TABLE 37 UK Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 38 UK Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 39 UK Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 40 UK Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 41 UK Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 42 UK Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 43 France Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
TABLE 44 France Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
TABLE 45 France Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 46 France Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 47 France Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 48 France Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 49 France Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 50 France Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 51 Russia Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
TABLE 52 Russia Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
TABLE 53 Russia Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 54 Russia Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 55 Russia Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 56 Russia Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 57 Russia Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 58 Russia Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 59 Spain Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
TABLE 60 Spain Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
TABLE 61 Spain Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 62 Spain Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 63 Spain Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 64 Spain Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 65 Spain Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 66 Spain Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 67 Italy Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
TABLE 68 Italy Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
TABLE 69 Italy Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 70 Italy Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 71 Italy Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 72 Italy Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 73 Italy Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 74 Italy Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 75 Rest of Europe Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
TABLE 76 Rest of Europe Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
TABLE 77 Rest of Europe Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 78 Rest of Europe Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 79 Rest of Europe Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 80 Rest of Europe Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 81 Rest of Europe Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 82 Rest of Europe Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 83 Key Information - Amneal Pharmaceuticals, INc.
TABLE 84 Key Information - Ipsen Pharma Biotech SAS
TABLE 85 Key information - Merz Pharma GmbH & Co. KGaA
TABLE 86 Key information - Mallinckrodt PLC
TABLE 87 Key Information - Teva Pharmaceuticals Industries Ltd.
TABLE 88 Key Information - Eisai Co., Ltd.
TABLE 89 Key Information - Endo International PLC
TABLE 90 Key Information - Vertical Pharmaceuticals, LLC
TABLE 91 Key Information - SteriMax Inc.
TABLE 92 Key Information - Metacel Pharmaceuticals, LLC.

List of Figures

FIG 1 Methodology for the research
FIG 2 Europe Muscle Relaxant Drugs Market Share by Drug Type, 2022
FIG 3 Europe Muscle Relaxant Drugs Market Share by Drug Type, 2029
FIG 4 Europe Muscle Relaxant Drugs Market by Drug Type, 2019 - 2029, USD Million
FIG 5 Europe Muscle Relaxant Drugs Market Share by Route of Administration, 2022
FIG 6 Europe Muscle Relaxant Drugs Market Share by Route of Administration, 2029
FIG 7 Europe Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2029, USD Million
FIG 8 Europe Muscle Relaxant Drugs Market Share by Distribution Channel, 2022
FIG 9 Europe Muscle Relaxant Drugs Market Share by Distribution Channel, 2029
FIG 10 Europe Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2029, USD Million
FIG 11 Europe Muscle Relaxant Drugs Market Share by Country, 2022
FIG 12 Europe Muscle Relaxant Drugs Market Share by Country, 2029
FIG 13 Europe Muscle Relaxant Drugs Market by Country, 2019 - 2029, USD Million

Europe Muscle Relaxant Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Route of Administration (Oral and Injectable), By Distribution Channel, By Country and Growth Forecast, 2023 - 2029

Description

Table of Contents